Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 9, Issue 3, pp. 354-369
PubMed
Published By
Print ISSN
Online ISSN
History
- Received September 29, 2018
- Revision received October 24, 2018
- Accepted November 2, 2018
- Published first December 5, 2018.
Article Versions
- Previous version (December 5, 2018 - 14:30).
- Previous version (February 7, 2019 - 05:48).
- Previous version (February 15, 2019 - 06:01).
- You are viewing the most recent version of this article.
Copyright & Usage
©2018 American Association for Cancer Research.
Author Information
- Sheau W. Lok1,2,3,
- James R. Whittle1,2,3,4,
- François Vaillant2,4,
- Charis E. Teh2,4,
- Louisa L. Lo3,4,
- Antonia N. Policheni2,4,
- Alice R.T. Bergin1,2,3,
- Jayesh Desai1,2,3,
- Sarah Ftouni3,
- Luke C. Gandolfo2,4,
- Danny Liew4,5,
- He K. Liu2,
- G. Bruce Mann1,3,4,6,
- Kate Moodie3,
- Anand Murugasu1,
- Bhupinder Pal2,4,7,
- Andrew W. Roberts1,2,4,
- Mark A. Rosenthal1,3,4,
- Kylie Shackleton1,2,
- Maria João Silva3,
- Zhen R. Siow1,2,3,
- Gordon K. Smyth2,4,
- Leanne Taylor1,
- Avraham Travers1,2,3,
- Belinda Yeo7,8,
- Miriam M. Yeung3,
- Andjelija Zivanovic Bujak3,4,
- Sarah-Jane Dawson3,4,
- Daniel H.D. Gray2,4,
- Jane E. Visvader2,4 and
- Geoffrey J. Lindeman1,2,3,4,*
- 1The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
- 2The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
- 3The Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- 4The University of Melbourne, Melbourne, Victoria, Australia.
- 5School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
- 6The Royal Women's Hospital, Melbourne, Victoria, Australia.
- 7Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.
- 8Austin Health, Melbourne, Victoria, Australia.
- ↵*Corresponding Author:
Geoffrey J. Lindeman, The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia. Phone: 61-3-9345-2611; Fax: 61-3-9347-0852; E-mail: lindeman{at}wehi.edu.au
S.W. Lok and J.R. Whittle contributed equally to this article.
March 2019
Volume 9, Issue 3
Volume 9, Issue 3
A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2–Positive Metastatic Breast Cancer
Jump to section
Advertisement